Benjamin Rovinski

SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA.

Robert Bosch Healthcare Systems, Inc. was engaged in the design, development, and distribution of patient monitoring systems. The firm offered health management programs delivering personalized daily monitoring and patient education. The company was founded in 1988 and was headquartered in Palo Alto, CA.

Avalon Pharmaceuticals, Inc. was a biopharmaceutical company focused on the discovery, development and commercialization of cancer therapeutics. The company was founded in November 1999 and headquartered in Germantown, MD.

Protana, Inc. provides pharmaceutical and biotechnology research services. It provides protein identification, protein interaction mapping, differential analysis, biomarker discovery, chemical proteomics, and insilico drug design services. The company provides services to medical and biopharmaceutical companies. The company headquartered in Toronto, Canada.

Sanofi Pasteur Ltd. develops, manufactures, and markets vaccines and immunotherapeutic products. It offers vaccines for haemophilus influenza type B (Hib), diphtheria, pertussis, poliomyelitis, tetanus, hepatitis A, influenza, poliomyelitis, rabies, meningococcal disease, typhoid fever, and yellow fever, as well as oncology products for bladder cancers. The company was founded John Gerald FitzGerald in 1914 and is headquartered in Toronto, Canada.

Cervelo Pharmaceuticals Ltd. engages in the preparation of pharmaceuticals. It develops drug product candidates for neuropathic, inflammatory, and neurodegenerative diseases. The company was founded by Anthony J. Giovinazzo in 2006 and is headquartered in Mississauga, Canada.

Ontario Genomics Institute (Private Equity) is a Venture Capital firm in UK. The firm was founded in 2001. The firm is headquartered in London.

Vascular Pharmaceuticals, Inc. develops and commercializes therapeutics for the treatment of diabetics. It provides new treatment options to individuals living with diabetic complications such as nephropathy. The company was founded by David R. Clemmons and Laura Maile in 2005 and is headquartered in Research Triangle Park, NC.

Antios Therapeutics, Inc. operates as a biopharmaceutical company devoted to developing therapies for viral diseases. The company was founded by Abel De La Rosa, Doug Mayers and Idean Marvasty on October 30, 2018 and is headquartered in Atlanta, GA.

Bright Angel Therapeutics, Inc. is a pre-clinical stage biotechnology company. It is focused on the development of novel therapeutics for the treatment of drug-resistant and life-threatening fungal infections. The company is headquartered in Toronto, Canada.